Filing summary
Entity discrepancy: The request identifies Firefly Neuroscience, Inc., but the supplied Form 10-Q is for Information Analysis Incorporated (IAI), a Virginia company. This summary reflects the filing text, not the named company in the request.
Business context and reporting period
This unaudited Form 10-Q covers the quarter and nine months ended September 30, 2012; the balance sheet compares September 30, 2012 with December 31, 2011. IAI provides IT consulting, software modernization and migration, and software products and maintenance, primarily for government and commercial customers. Three customers accounted for 31.4%, 21.5%, and 19.7% of nine-month revenue, respectively.
Key financial metrics
| Metric | Q3 2012 | Q3 2011 | Nine months 2012 | Nine months 2011 |
|---|---|---|---|---|
| Revenue | $1.736 million | $1.663 million | $5.684 million | $4.707 million |
| Gross profit / margin | $570,000 / 32.8% | $682,000 / 41.0% | $1.819 million / 32.0% | $1.800 million / 38.2% |
| Operating income | $41,777 | $61,240 | $67,614 | $95,320 |
| Net income | $43,422 | $63,133 | $72,316 | $101,320 |
| Net margin | 2.5% | 3.8% | 1.3% | 2.2% |
| Operating cash flow | Not separately reported | Not separately reported | $1.043 million | $(18,314) |
At September 30, cash was $2.312 million; current assets were $3.409 million and current liabilities $1.338 million, yielding working capital of about $2.071 million. The company reported no non-current liabilities and no borrowings on its revolving credit line. The $1 million line had $596,000 available based on receivables and was scheduled to expire December 1, 2012. No interest was paid in either nine-month period.
Material changes versus comparable periods
- Q3 revenue grew 4.4%; professional-services revenue rose 2.5% and software revenue 11.8%. Nine-month revenue grew 20.8%, including 8.7% growth in services and 59.2% growth in software.
- Despite higher revenue, gross margin fell in both comparisons. Q3 gross margin declined to 32.8% from 41.0%; nine-month gross margin declined to 32.0% from 38.2%. Management attributed this to lower-margin software sales, competitive bidding, and reduced activity or expiration of higher-margin service contracts.
- Net income fell 31.2% in Q3 and 28.6% for the nine months. Nine-month SG&A excluding commissions increased 5.2%, while commissions declined 2.9%.
- Cash increased $1.031 million during the first nine months. The cash-flow improvement primarily reflected collections and reductions in receivables and prepaid balances, partly offset by lower accounts payable and deferred revenue.
- Accounts receivable, net, fell to $936,097 from $2.890 million at year-end; the allowance for doubtful accounts was zero at September 30, compared with $141,721 at December 31, 2011.
Outlook, commentary, risks and unusual items
Management said current cash and the operating plan should meet cash requirements for the next 12 months and beyond. It reported no material capital-expenditure commitments or off-balance-sheet arrangements. No formal revenue or earnings guidance was provided. The employee note’s maturity was extended from August 10, 2013 to July 10, 2015.
Risks highlighted include federal funding and contracting changes, customer concentration, competition, contract cost and timing estimates, subcontractor and supplier performance, key-person dependence, technology change, and reliance on third-party software suppliers. Federal contracts may be subject to periodic funding; DCAA audits could lead to renegotiated billings, although management described material audit risk as minimal. The filing reported no legal proceedings and no material changes to the prior annual report’s risk factors.
Management stated disclosure controls were effective, but the evaluation date cited in the controls section is March 31, 2012, rather than the quarter-end date. The filing reports no material control changes during the quarter. No material subsequent events were reported.
Important facts for investors to verify
- Confirm the intended issuer: the provided filing is IAI’s 2012 third-quarter 10-Q, not a filing identified as Firefly Neuroscience.
- Verify the customer concentration figures and the identity and renewal/funding status of the major contracts.
- Check the revolving credit facility’s expiration and renewal status; the filing said it expired December 1, 2012.
- Assess whether the reduced gross margins, particularly on software sales, continued after the reporting period.
- Review the controls evaluation date discrepancy and the underlying annual-report risk disclosures.